We recently found that MCPIP1 and MCP1 negatively regulate DR5 protein levels, including cell surface DR5 and cancer cell responses to TRAIL, primarily through modulating DUB-mediated protein autophagic/lysosomal degradation [98]. Here, CCL2 is linked to cancer.